What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News A new mortality prediction calculator for patients with infective endocarditis could save lives The new online tool can assist medical decision-making in patients suffering from infective endocarditis who need to undergo cardiac surgery, which is a high risk operation. News Vall d'Hebron leads a multicenter study that will assess a faster workflow for the management of patients with stroke The international multi-centric study WE-TRUST will assess the impact of the "Direct to Angiography" approach thanks to a computed tomography technology developed and improved by Philips. News Dr. Antoni Soriano, awarded by the European Society of Paediatric Infectious Diseases (ESPID) The VHIR researcher has been recognized for his research on the low transmissibility of COVID-19 from pediatric patients. News Vall d'Hebron releases four innovative works on different systemic diseases Articles from the Systemic Diseases research group at the VHIR focus on scleroderma, antiphospholipid syndrome, Sjögren's syndrome, and the relationship between cancer and inflammatory myopathy. News Vall d'Hebron participates in the largest study on non-rhabdomyosarcoma pediatric soft tissue sarcomas The pediatric surgeon Gabriela Guillén is a co-author in this study of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) that lays the foundations for the treatment of this type of tumors. News Dr. María José Soler, elected editor-in-chief of the Clinical Kidney Journal Dr. María José Soler, nephrologist at Vall d'Hebron and the VHIR, will become, in June 2022, the first editor-in-chief of the specialized journal Clinical Kidney Journal. News Six Vall d'Hebron research groups receive grants from the Strategic Plan for Research and Innovation in Health (PERIS) The projects will investigate issues such as stroke and endometrial cancer prevention. News IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases This investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID), like rheumatoid arthritis, psoriasis, Crohn's disease or systemic lupus erythematosus. News New strategies to fight aggressive breast cancer CIBER-BBN and VHIR researchers design a new system to transport a drug effective against tumour stem cells, the most resistant ones, through nanoparticles. News Vall d'Hebron tests robotic thrombectomy for stroke with a pioneering study in Europe The procedure, led by Dr. Alejandro Tomasello, aims to reduce intervention time to a minimum by working over long distances. Pagination Previous page ‹‹ Page 57 Next page ››